Health Care Equipment & Services

Inside view: Simulations Plus insiders sold all holdings for $18.50/share after merger with SP Evolution, highlighting potential short‑term gains and future volatility.

Discover why insider buying and strong AI‑driven evidence give Hinge Health a competitive edge in musculoskeletal care and stock performance.

Elevance Health CFO sells 4,161 shares after exercising restricted shares, showing routine liquidity while maintaining confidence in the company’s growth prospects.

CEO insider buying at NewGenIVF signals confidence in upside, reducing dilution and boosting investor sentiment amid biotech growth plans.

Insider buying by L1 Capital at ANTERIS Technologies shows bullish confidence amid a volatile period, hinting at long‑term upside for investors.

Firefly Neuroscience’s DSU grants show executive confidence, aligning incentives with the company’s digital‑health, AI‑driven neural‑interface roadmap and the evolving value‑based reimbursement landscape.

Insider selling at Innovage Holding: Nicole Damato’s recent 23,814‑share plan trade shows liquidity management, not a wipe‑out, amid a new public offering and strategic expansion.

CEO Ben‑Noon Dagi Shahar’s fresh $0.71 share purchase fuels hope that QTREX’s next‑gen respiratory‑support platform could rebound a 42% price dip and deliver long‑term growth.

Inside Doximity’s latest RSU grant: President Steven Zatz adds $4M in shares, showing confidence in the company’s future growth and aligning executive incentives with shareholder value.

Explore why Abbott Laboratories’ insider sales may hint at future challenges—and how the company’s diverse diagnostics, devices, generics, and nutrition strengths could shape investors’ next steps.